Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-29 Sale | 2025-09-03 5:16 pm | Sionna Therapeutics Inc. | SION | Ridloff Elena CFO & Head of Corp. Dev. | 9,584 | $25.09 | $240,442 | 38,532 (Direct) | View |
| 2025-08-26 Sale | 2025-08-28 5:40 pm | Sionna Therapeutics Inc. | SION | Ridloff Elena CFO & Head of Corp. Dev. | 23,416 | $25.7 | $601,858 | 48,116 (Direct) | View |
| 2025-08-19 Sale | 2025-08-21 4:04 pm | Sionna Therapeutics Inc. | SION | Ridloff Elena CFO & Head of Corp. Dev. | 52,000 | $21.62 | $1,124,335 | 71,532 (Direct) | View |
| 2025-06-11 Sale | 2025-06-11 4:47 pm | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 4,500 | $50 | $225,000 | 4,500 (Direct) | View |
| 2025-06-03 Sale | 2025-06-03 6:30 pm | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 12,000 | $46.1 | $553,200 | 0 (Direct) | View |
| 2021-04-30 Sale | 2021-04-30 6:55 pm | ACADIA PHARMACEUTICALS INC | ACAD | Ridloff Elena EVP and CFO | 1,032 | $20.33 | $20,981 | 17,044 (Direct) | View |
| 2021-02-04 Sale | 2021-02-08 9:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Ridloff Elena EVP and CFO | 2,051 | $50.61 | $103,801 | 8,340 (Direct) | View |
| 2021-01-06 Sale | 2021-01-08 7:29 pm | ACADIA PHARMACEUTICALS INC | ACAD | Ridloff Elena EVP and CFO | 1,016 | $53.34 | $54,193 | 13,774 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-25 Option Award | 2025-06-26 9:00 pm | N/A 2035-06-24 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2025-06-20 Equity Swap | 2025-06-20 4:15 pm | N/A N/A | Kronos Bio Inc. | KRON | Ridloff Elena Director | 25,296 | $0.57 | 0 (Direct) | View |
| 2025-06-11 Exercise | 2025-06-11 4:47 pm | N/A 2032-06-29 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 4,500 | $0 | 4,500 (Direct) | View |
| 2025-06-11 Exercise | 2025-06-11 4:47 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 4,500 | $20.29 | 4,500 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-03 6:30 pm | N/A N/A | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 12,000 | $27.67 | 0 (Direct) | View |
| 2025-06-03 Exercise | 2025-06-03 6:30 pm | N/A 2033-06-15 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 12,000 | $0 | 0 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-10 4:05 pm | N/A 2035-02-05 | Sionna Therapeutics Inc. | SION | Ridloff Elena CFO & Head of Corp. Dev. | 157,820 | $0 | 157,820 (Direct) | View |
Ownership | 2025-02-06 9:00 pm | N/A N/A | Sionna Therapeutics Inc. | SION | Ridloff Elena CFO & Head of Corp. Dev. | 0 | $0 | 411,397 (Direct) | View |
| 2024-06-25 Option Award | 2024-06-26 4:37 pm | N/A 2034-06-24 | Kronos Bio Inc. | KRON | Ridloff Elena Director | 28,333 | $0 | 42,296 (Direct) | View |
| 2024-06-18 Option Award | 2024-06-20 5:00 pm | N/A 2034-06-17 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-22 Option Award | 2023-06-26 4:15 pm | N/A 2033-06-21 | Kronos Bio Inc. | KRON | Ridloff Elena Director | 28,333 | $0 | 30,963 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 4:15 pm | N/A 2033-06-14 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-06-29 Option Award | 2022-07-01 4:05 pm | N/A 2032-06-28 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-29 4:10 pm | N/A 2032-06-21 | Kronos Bio Inc. | KRON | Ridloff Elena Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 4:05 pm | N/A 2032-06-14 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-06-16 Option Award(A) | 2022-04-15 4:15 pm | N/A 2031-06-15 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 10,459 | $0 | 10,459 (Direct) | View |
| 2021-03-12 Option Award(A) | 2022-04-15 4:15 pm | N/A 2031-03-11 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 20,919 | $0 | 20,919 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 9:20 pm | N/A 2031-06-21 | Kronos Bio Inc. | KRON | Ridloff Elena Director | 15,450 | $0 | 15,450 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 4:49 pm | N/A 2031-06-15 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 20,063 | $0 | 20,063 (Direct) | View |
| 2021-04-29 Exercise | 2021-04-30 6:55 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Ridloff Elena EVP and CFO | 3,245 | $0 | 17,044 (Direct) | View |
| 2021-03-12 Option Award | 2021-03-16 5:22 pm | N/A 2031-03-11 | Kymera Therapeutics Inc. | KYMR | Ridloff Elena Director | 40,127 | $0 | 40,127 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 9:47 pm | N/A 2031-02-23 | ACADIA PHARMACEUTICALS INC | ACAD | Ridloff Elena EVP and CFO | 46,070 | $0 | 46,070 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 9:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Ridloff Elena EVP and CFO | 6,490 | $0 | 8,340 (Direct) | View |
| 2021-01-06 Exercise | 2021-01-08 7:29 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Ridloff Elena EVP and CFO | 3,738 | $0 | 13,774 (Direct) | View |